REGN logo

REGN Cash From Investing

Annual CFI:

-$2.47B+$717.00M(+22.51%)
December 31, 2024

Summary

  • As of today, REGN annual cash from investing is -$2.47 billion, with the most recent change of +$717.00 million (+22.51%) on December 31, 2024.
  • During the last 3 years, REGN annual cash from investing has risen by +$2.92 billion (+54.16%).
  • REGN annual cash from investing is now -2021.13% below its all-time high of $128.47 million, reached on December 31, 2011.

Performance

REGN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

Quarterly CFI:

-$1.09B-$1.74B(-268.96%)
June 30, 2025

Summary

  • As of today, REGN quarterly cash from investing is -$1.09 billion, with the most recent change of -$1.74 billion (-268.96%) on June 30, 2025.
  • Over the past year, REGN quarterly cash from investing has dropped by -$536.80 million (-96.34%).
  • REGN quarterly cash from investing is now -175.27% below its all-time high of $1.45 billion, reached on June 30, 2020.

Performance

REGN Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

TTM CFI:

-$670.30M-$536.80M(-402.10%)
June 30, 2025

Summary

  • As of today, REGN TTM cash from investing is -$670.30 million, with the most recent change of -$536.80 million (-402.10%) on June 30, 2025.
  • Over the past year, REGN TTM cash from investing has increased by +$2.14 billion (+76.12%).
  • REGN TTM cash from investing is now -212.75% below its all-time high of $594.50 million, reached on June 30, 2020.

Performance

REGN TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

REGN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+22.5%-96.3%+76.1%
3Y3 Years+54.2%-164.3%+89.8%
5Y5 Years-21.7%-175.3%-2708.2%

REGN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+54.2%-269.0%+54.2%-402.1%+86.5%
5Y5-Year-3395.9%+54.2%-269.0%+55.1%-2708.2%+89.8%
All-TimeAll-Time-2021.1%+54.2%-175.3%+55.1%-212.8%+89.8%

REGN Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$1.09B(-269.0%)
-$670.30M(-402.1%)
Mar 2025
-
$647.50M(+84.7%)
-$133.50M(+94.6%)
Dec 2024
-$2.47B(+22.5%)
$350.60M(+161.0%)
-$2.47B(+14.4%)
Sep 2024
-
-$574.40M(-3.1%)
-$2.88B(-2.8%)
Jun 2024
-
-$557.20M(+67.0%)
-$2.81B(+39.5%)
Mar 2024
-
-$1.69B(-2448.5%)
-$4.64B(-45.6%)
Dec 2023
-$3.19B(+15.8%)
-$66.20M(+86.7%)
-$3.19B(+36.0%)
Sep 2023
-
-$496.30M(+79.2%)
-$4.98B(-16.1%)
Jun 2023
-
-$2.39B(-912.7%)
-$4.29B(-85.2%)
Mar 2023
-
-$235.70M(+87.3%)
-$2.31B(+38.8%)
Dec 2022
-$3.78B(+29.7%)
-$1.86B(-1066.0%)
-$3.78B(+3.9%)
Sep 2022
-
$192.30M(+146.5%)
-$3.94B(+40.0%)
Jun 2022
-
-$413.90M(+75.7%)
-$6.57B(-8.9%)
Mar 2022
-
-$1.71B(+15.3%)
-$6.03B(-12.0%)
Dec 2021
-$5.38B(-7527.1%)
-$2.01B(+17.5%)
-$5.38B(-46.4%)
Sep 2021
-
-$2.44B(-2038.6%)
-$3.68B(-82.6%)
Jun 2021
-
$125.80M(+111.9%)
-$2.01B(-193.4%)
Mar 2021
-
-$1.06B(-247.2%)
-$686.40M(-872.2%)
Dec 2020
-$70.60M(+96.5%)
-$305.00M(+60.7%)
-$70.60M(-374.7%)
Sep 2020
-
-$775.80M(-153.4%)
$25.70M(-95.7%)
Jun 2020
-
$1.45B(+427.9%)
$594.50M(+135.1%)
Mar 2020
-
-$443.20M(-112.4%)
-$1.69B(+16.4%)
Dec 2019
-$2.03B(-38.6%)
-$208.70M(-0.8%)
-$2.03B(+2.7%)
Sep 2019
-
-$207.00M(+75.2%)
-$2.09B(+3.7%)
Jun 2019
-
-$836.00M(-7.7%)
-$2.16B(-19.4%)
Mar 2019
-
-$776.10M(-191.9%)
-$1.81B(-24.0%)
Dec 2018
-$1.46B(-45.5%)
-$265.91M(+7.3%)
-$1.46B(+4.6%)
Sep 2018
-
-$286.71M(+40.9%)
-$1.53B(+4.5%)
Jun 2018
-
-$484.97M(-14.0%)
-$1.61B(-24.4%)
Mar 2018
-
-$425.41M(-26.7%)
-$1.29B(-28.4%)
Dec 2017
-$1.01B(+4.0%)
-$335.75M(+6.4%)
-$1.01B(-6.8%)
Sep 2017
-
-$358.88M(-110.6%)
-$940.79M(+4.8%)
Jun 2017
-
-$170.41M(-21.6%)
-$987.76M(+13.6%)
Mar 2017
-
-$140.14M(+48.4%)
-$1.14B(-9.2%)
Dec 2016
-$1.05B(-15.3%)
-$271.36M(+33.1%)
-$1.05B(-16.5%)
Sep 2016
-
-$405.85M(-24.5%)
-$898.85M(-15.8%)
Jun 2016
-
-$326.01M(-646.3%)
-$776.17M(+5.6%)
Mar 2016
-
-$43.69M(+64.6%)
-$821.80M(+9.5%)
Dec 2015
-$907.60M(-115.7%)
-$123.30M(+56.5%)
-$907.60M(-24.7%)
Sep 2015
-
-$283.17M(+23.8%)
-$727.66M(-28.2%)
Jun 2015
-
-$371.65M(-187.0%)
-$567.55M(-80.7%)
Mar 2015
-
-$129.48M(-328.6%)
-$314.03M(+25.4%)
Dec 2014
-$420.78M(-18.4%)
$56.65M(+146.0%)
-$420.78M(+28.4%)
Sep 2014
-
-$123.07M(-4.2%)
-$587.37M(+13.5%)
Jun 2014
-
-$118.12M(+50.0%)
-$678.75M(-52.9%)
Mar 2014
-
-$236.23M(-114.9%)
-$444.00M(-24.9%)
Dec 2013
-$355.45M(-338.4%)
-$109.95M(+48.7%)
-$355.45M(-130.2%)
Sep 2013
-
-$214.45M(-283.9%)
-$154.40M(-1467.1%)
Jun 2013
-
$116.63M(+179.0%)
$11.29M(+104.6%)
Mar 2013
-
-$147.69M(-262.1%)
-$244.52M(-201.6%)
Dec 2012
-$81.07M(-163.1%)
$91.10M(+286.9%)
-$81.07M(+60.7%)
Sep 2012
-
-$48.75M(+65.0%)
-$206.08M(-30.2%)
Jun 2012
-
-$139.19M(-982.8%)
-$158.23M(-227.7%)
Mar 2012
-
$15.77M(+146.5%)
$123.89M(-3.6%)
Dec 2011
$128.47M(+129.6%)
-$33.91M(-3655.0%)
$128.47M(+167.1%)
Sep 2011
-
-$903.00K(-100.6%)
-$191.40M(-37.2%)
Jun 2011
-
$142.94M(+602.5%)
-$139.49M(+49.8%)
Mar 2011
-
$20.35M(+105.8%)
-$277.83M(+36.0%)
Dec 2010
-$434.15M(>-9900.0%)
-$353.77M(-793.6%)
-$434.15M(-336.1%)
Sep 2010
-
$51.00M(+1010.0%)
-$99.55M(+39.3%)
Jun 2010
-
$4.59M(+103.4%)
-$164.02M(-70.3%)
Mar 2010
-
-$135.98M(-609.3%)
-$96.29M(>-9900.0%)
Dec 2009
$146.00K(-99.5%)
-$19.17M(-42.3%)
$146.00K(-99.9%)
Sep 2009
-
-$13.47M(-118.6%)
$103.99M(-42.3%)
Jun 2009
-
$72.33M(+282.9%)
$180.24M(+486.2%)
Mar 2009
-
-$39.54M(-146.7%)
-$46.67M(-251.4%)
Dec 2008
$30.82M
$84.67M(+34.9%)
$30.82M(+277.2%)
DateAnnualQuarterlyTTM
Sep 2008
-
$62.78M(+140.6%)
-$17.39M(+78.8%)
Jun 2008
-
-$154.58M(-507.4%)
-$82.04M(-411.6%)
Mar 2008
-
$37.94M(+4.1%)
$26.33M(+130.7%)
Dec 2007
-$85.72M(+44.7%)
$36.46M(+2045.7%)
-$85.72M(+70.0%)
Sep 2007
-
-$1.87M(+95.9%)
-$285.40M(-31.5%)
Jun 2007
-
-$46.20M(+37.7%)
-$217.06M(+0.6%)
Mar 2007
-
-$74.11M(+54.6%)
-$218.35M(-40.8%)
Dec 2006
-$155.10M(-234.3%)
-$163.21M(-345.6%)
-$155.10M(-564.2%)
Sep 2006
-
$66.46M(+240.0%)
$33.41M(+162.1%)
Jun 2006
-
-$47.48M(-336.8%)
$12.75M(-85.2%)
Mar 2006
-
-$10.87M(-143.0%)
$86.20M(-25.4%)
Dec 2005
$115.49M(+1030.1%)
$25.30M(-44.8%)
$115.49M(+2.6%)
Sep 2005
-
$45.80M(+76.4%)
$112.56M(+110.9%)
Jun 2005
-
$25.97M(+40.9%)
$53.37M(+228.3%)
Mar 2005
-
$18.43M(-17.6%)
-$41.59M(-506.9%)
Dec 2004
$10.22M(+116.0%)
$22.37M(+267.0%)
$10.22M(+106.1%)
Sep 2004
-
-$13.39M(+80.6%)
-$168.64M(-72.7%)
Jun 2004
-
-$68.99M(-198.2%)
-$97.62M(-76.1%)
Mar 2004
-
$70.23M(+144.9%)
-$55.43M(+13.2%)
Dec 2003
-$63.84M(-9.1%)
-$156.49M(-371.6%)
-$63.84M(-150.0%)
Sep 2003
-
$57.63M(+315.1%)
$127.58M(+27.5%)
Jun 2003
-
-$26.80M(-143.3%)
$100.06M(+10.9%)
Mar 2003
-
$61.82M(+77.0%)
$90.23M(+254.2%)
Dec 2002
-$58.52M(+22.4%)
$34.94M(+16.1%)
-$58.52M(+51.1%)
Sep 2002
-
$30.10M(+182.2%)
-$119.66M(+30.1%)
Jun 2002
-
-$36.63M(+57.9%)
-$171.25M(-1.2%)
Mar 2002
-
-$86.93M(-231.7%)
-$169.20M(-124.4%)
Dec 2001
-$75.39M(-30.7%)
-$26.21M(-22.0%)
-$75.39M(-18.0%)
Sep 2001
-
-$21.49M(+37.9%)
-$63.91M(+27.3%)
Jun 2001
-
-$34.58M(-602.1%)
-$87.88M(-64.9%)
Mar 2001
-
$6.89M(+146.7%)
-$53.30M(+7.6%)
Dec 2000
-$57.68M(-430.2%)
-$14.73M(+67.6%)
-$57.68M(-15.6%)
Sep 2000
-
-$45.46M(>-9900.0%)
-$49.90M(-875.4%)
Jun 2000
-
$8000.00(-99.7%)
$6.43M(-36.6%)
Mar 2000
-
$2.51M(+136.1%)
$10.14M(-41.9%)
Dec 1999
$17.47M(+615.6%)
-$6.95M(-164.0%)
$17.47M(-36.6%)
Sep 1999
-
$10.87M(+192.6%)
$27.57M(+114.3%)
Jun 1999
-
$3.71M(-62.2%)
$12.87M(-25.5%)
Mar 1999
-
$9.84M(+211.9%)
$17.28M(+608.0%)
Dec 1998
$2.44M(+106.3%)
$3.15M(+182.2%)
$2.44M(+117.3%)
Sep 1998
-
-$3.83M(-147.2%)
-$14.11M(+26.0%)
Jun 1998
-
$8.13M(+262.4%)
-$19.08M(+54.3%)
Mar 1998
-
-$5.01M(+62.6%)
-$41.71M(-7.2%)
Dec 1997
-$38.90M(+12.2%)
-$13.40M(-52.3%)
-$38.90M(-2.6%)
Sep 1997
-
-$8.80M(+39.3%)
-$37.90M(-16.3%)
Jun 1997
-
-$14.50M(-559.1%)
-$32.60M(+0.6%)
Mar 1997
-
-$2.20M(+82.3%)
-$32.80M(+26.0%)
Dec 1996
-$44.30M(-634.5%)
-$12.40M(-254.3%)
-$44.30M(-53.3%)
Sep 1996
-
-$3.50M(+76.2%)
-$28.90M(-18.4%)
Jun 1996
-
-$14.70M(-7.3%)
-$24.40M(-916.7%)
Mar 1996
-
-$13.70M(-556.7%)
-$2.40M(-132.4%)
Dec 1995
-$6.03M(-129.2%)
$3.00M(+200.0%)
$7.40M(-67.5%)
Sep 1995
-
$1.00M(-86.3%)
$22.80M(-10.6%)
Jun 1995
-
$7.30M(+287.2%)
$25.50M(+8.1%)
Mar 1995
-
-$3.90M(-121.2%)
$23.60M(-26.0%)
Dec 1994
$20.65M(+187.6%)
$18.40M(+397.3%)
$31.90M(+878.0%)
Sep 1994
-
$3.70M(-31.5%)
-$4.10M(+80.4%)
Jun 1994
-
$5.40M(+22.7%)
-$20.90M(-2.0%)
Mar 1994
-
$4.40M(+125.0%)
-$20.50M(+13.1%)
Dec 1993
-$23.58M(-389.3%)
-$17.60M(-34.4%)
-$23.60M(-807.7%)
Sep 1993
-
-$13.10M(-325.9%)
-$2.60M(-122.2%)
Jun 1993
-
$5.80M(+346.2%)
$11.70M(+56.0%)
Mar 1993
-
$1.30M(-61.8%)
$7.50M(-8.5%)
Dec 1992
$8.15M(+110.5%)
$3.40M(+183.3%)
$8.20M(+70.8%)
Sep 1992
-
$1.20M(-25.0%)
$4.80M(+33.3%)
Jun 1992
-
$1.60M(-20.0%)
$3.60M(+80.0%)
Mar 1992
-
$2.00M
$2.00M
Dec 1991
-$77.64M
-
-

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of REGN is -$2.47B

What is the all-time high annual cash from investing for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual cash from investing is $128.47M

What is Regeneron Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, REGN annual cash from investing has changed by +$717.00M (+22.51%)

What is Regeneron Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of REGN is -$1.09B

What is the all-time high quarterly cash from investing for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly cash from investing is $1.45B

What is Regeneron Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, REGN quarterly cash from investing has changed by -$536.80M (-96.34%)

What is Regeneron Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of REGN is -$670.30M

What is the all-time high TTM cash from investing for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high TTM cash from investing is $594.50M

What is Regeneron Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, REGN TTM cash from investing has changed by +$2.14B (+76.12%)
On this page